Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,084 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Follow-Up Questions
Almirall SA 的 CEO 是誰？
Mr. Carlos Gallardo Pique 是 Almirall SA 的 Executive Chairman of the Board，自 2014 加入公司。
LBTSF 股票的價格表現如何？
LBTSF 的當前價格為 $0，在上個交易日 decreased 了 0%。
Almirall SA 的主要業務主題或行業是什麼？
Almirall SA 屬於 Pharmaceuticals 行業，該板塊是 Health Care
